Cuprina Holdings (Cayman) Limited (CUPR)
NASDAQ: CUPR · Real-Time Price · USD
4.540
-0.210 (-4.42%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Company Description
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name.
It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment.
The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.
Cuprina Holdings (Cayman) Limited
| Country | Singapore |
| Founded | 2019 |
| IPO Date | Apr 10, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 14 |
| CEO | Yong Qi Quek |
Contact Details
Address: #06-08, 1090 Lower Delta Road Singapore, 169201 Singapore | |
| Phone | 65 8512 7275 |
| Website | cuprina.com.sg |
Stock Details
| Ticker Symbol | CUPR |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | SGD |
| IPO Price | $4.00 |
| CIK Code | 0001995704 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| David Quek Yong Qi | Director and Chief Executive Officer |
| Baptista Carl Marc | Director and Chief Technology Officer |
| Teo Peng Kwang | Director |
| Jimmy Lee Peng Siew | Director |
| Koh Pee Keat | Independent Director |
| Ivan Ng | Independent Director |
| Natasha Kaur Raina | Independent Director |
| Chan Tat Jing | Financial Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2025 | NT 20-F | Notification of inability to timely file Form 20-F |
| Apr 11, 2025 | 6-K | Report of foreign issuer |
| Apr 10, 2025 | 424B4 | Prospectus |
| Apr 9, 2025 | CERT | Certification by an exchange approving securities for listing |
| Apr 9, 2025 | 8-A12B | Registration of securities |
| Mar 31, 2025 | EFFECT | Notice of Effectiveness |
| Feb 14, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Feb 5, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Jan 7, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Dec 17, 2024 | RW | Filing |